In addition to standard medical care, the Division of Haematology offers patients all the advantages of a top international institution. A broad spectrum of cutting-edge diagnostics and innovative therapies (chemotherapy, immunotherapy, stem cell transplantation and other cellular immunotherapy, innovative coagulation therapy) is available.
To constantly improve therapies and develop new treatment methods for you, our division conducts clinical trials and scientific projects in basic research. Many of our patients have the opportunity to participate in these clinical trials and gain access to innovative therapies that have not yet been approved. We also investigate risk and prognosis factors for many diseases as well as mechanisms of disease development.